| 持有 昭衍新药(603127)的基金 |
| 报告期：2023-03-31 |
| 序号 |
基金代码 |
基金简称 |
持仓市值(元) |
持仓数量(股) |
占基金净值比例(%) |
| 1 | 002708 | 大摩健康产业混合 | 120,995,948.92 | 2,310,847.00 | 4.48 |
| 2 | 070099 | 嘉实优质企业混合 | 72,839,305.00 | 1,391,125.00 | 4.84 |
| 3 | 290006 | 泰信蓝筹精选混合 | 63,297,794.56 | 1,208,896.00 | 4.41 |
| 4 | 005535 | 泰信竞争优选混合 | 60,846,875.32 | 1,162,087.00 | 4.83 |
| 5 | 010276 | 嘉实优质精选混合C | 57,791,250.44 | 1,103,729.00 | 4.82 |
| 6 | 010275 | 嘉实优质精选混合A | 57,791,250.44 | 1,103,729.00 | 4.82 |
| 7 | 003231 | 创金合信医疗保健股票C | 48,552,694.96 | 927,286.00 | 4.94 |
| 8 | 003230 | 创金合信医疗保健股票A | 48,552,694.96 | 927,286.00 | 4.94 |
| 9 | 009893 | 大摩优悦安和混合 | 20,480,352.20 | 391,145.00 | 6.20 |
| 10 | 000870 | 嘉实新收益混合 | 17,596,101.60 | 336,060.00 | 4.99 |
| 11 | 009840 | 东财量化精选混合A | 8,026,788.00 | 153,300.00 | 4.41 |
| 12 | 009841 | 东财量化精选混合C | 8,026,788.00 | 153,300.00 | 4.41 |
| 13 | 001056 | 北信瑞丰健康生活主题灵活配置混合 | 6,126,120.00 | 117,000.00 | 5.11 |
| 14 | 005062 | 博时中证500指数增强A | 5,199,348.00 | 99,300.00 | 1.08 |
| 15 | 005795 | 博时中证500指数增强C | 5,199,348.00 | 99,300.00 | 1.08 |
| 16 | 009613 | 上银中证500指数增强A | 2,305,934.40 | 44,040.00 | 1.13 |
| 17 | 009614 | 上银中证500指数增强C | 2,305,934.40 | 44,040.00 | 1.13 |
| 18 | 290005 | 泰信优势增长混合 | 1,905,904.00 | 36,400.00 | 5.71 |
| 19 | 006087 | 华泰柏瑞中证500ETF联接C | 29,321.60 | 560.00 | 0.01 |
| 20 | 001214 | 华泰柏瑞中证500ETF联接A | 29,321.60 | 560.00 | 0.01 |
| 21 | 006909 | 华夏战略新兴成指ETF联接A | 7,330.40 | 140.00 | 0.00 |
| 22 | 006910 | 华夏战略新兴成指ETF联接C | 7,330.40 | 140.00 | 0.00 |
